Menu

• Ask a Health Expert about GRAFT VERSUS HOST DISEASE IN LUNG
• Post Your Side Effect related to GRAFT VERSUS HOST DISEASE IN LUNG
• GRAFT VERSUS HOST DISEASE IN LUNG and FDA Warnings
• GRAFT VERSUS HOST DISEASE IN LUNG in Patients Wiki
• Report GRAFT VERSUS HOST DISEASE IN LUNG in Drug Side Effect Survey

GRAFT VERSUS HOST DISEASE IN LUNG side effect

What is GRAFT VERSUS HOST DISEASE IN LUNG ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Cyclosporine Side Effects Report #5682277-8
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on Mar 19, 2008. Male patient, child 12 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: bronchopulmonary aspergillosis, graft versus host disease in lung, obliterative bronchiolitis, pancytopenia, rash, thrombotic microangiopathy, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, METHOTREXATE, TACROLIMUS, MYCOPHENOLATE MOFETIL, AZATHIOPRINE, CYCLOPHOSPHAMIDE. Patient died.

Prograf Side Effects Report #5542932-7
PROGRAF problem was reported by a Physician from UNITED STATES on Nov 27, 2007. Female patient, 54 years of age, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease in skin, graft versus host disease in lung, . PROGRAF dosage: unknown. During the same period patient was treated with PREDNISOLONE ACETATE. Patient recovered.

Cyclosporine Side Effects Report #5680201-5
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on Mar 19, 2008. Female patient, child 10 years of age, was diagnosed with stem cell transplant, prophylaxis against graft versus host disease and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: blast cell count increased, graft versus host disease, graft versus host disease in lung, obliterative bronchiolitis, . CYCLOSPORINE dosage: 1MG/KG/DAY. During the same period patient was treated with METHOTREXATE, TACROLIMUS, PREDNISOLONE. Patient died.

Alkeran Side Effects Report #5645345-2
ALKERAN problem was reported by a Physician from JAPAN on Feb 25, 2008. Male patient, 65 years of age, weighting 160.9 lb, was diagnosed with stem cell transplant and was treated with ALKERAN. After drug was administered, patient experienced the following problems/side effects: cryptogenic organising pneumonia, dyspnoea, graft versus host disease in lung, interstitial lung disease, . ALKERAN dosage: 140MGM2 PER DAY. During the same period patient was treated with FLUDARA, PREDONINE, METHOTREXATE, NEUTROGIN, CYCLOSPORINE. Patient died on 08/09/2007.